NOVOCART 3D-A Phase 3 Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D, Compared to Microfracture in the Treatment of Articular Cartilage Defects

Grants and Contracts Details

StatusFinished
Effective start/end date8/21/147/6/24

Funding

  • Premier Research International LLC: $345,532.00